CPT 66683, in plain terms, covers A surgical procedure to place an artificial iris inside the eye to improve appearance or function. CPT 66683 is referenced in 4 tracked payer policy changes from Regence BlueShield, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 66683 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 66683 on AAPC
Effective January 1, 2027, this policy establishes that iris prosthesis devices (including CustomFlex Artificial Iris) are classified as investigational for all indications and therefore non-covered. Billing teams must ensure claims for CPT 66683 and HCPCS C1839 are processed as investigational/non-covered and members are informed of financial responsibility prior to service delivery.
Aetna considers artificial retina devices, such as the Argus II, and artificial iris devices, such as the CustomFlex Artificial Iris, experimental, investigational, or unproven because their effectiveness has not been established. The CPT, HCPCS and ICD-10 codes listed in the policy are not covered for the indications listed in the policy, which include anterior segment reconstruction, aniridia, post-operative or traumatic aphakia and other iris defects. The policy states that there is insufficient evidence that artificial retina devices result in improved useful vision, and that the available evidence on artificial iris use for aniridia is weak.
Aetna considers artificial retina devices, such as the Argus II, experimental, investigational, or unproven because the effectiveness of these approaches has not been established. Aetna also considers artificial iris devices, such as the CustomFlex Artificial Iris, experimental, investigational, or unproven for anterior segment reconstruction and for the treatment of aniridia, post-operative or traumatic aphakia, and other iris defects. The listed CPT, HCPCS and ICD-10 codes are not covered for the indications listed in the policy.
Already effective July 1, 2025, Louisiana Blue accepts only the CAQH application for professional credentialing and recredentialing, and the Louisiana Standardized Credentialing Application was accepted for participating providers until June 30. Added codes in the Diagnostic and Therapeutic Services and Outpatient Procedure Services code ranges have effective dates of January 1, 2025 and April 1, 2025, including 15013, 15014, 38226 and 38227. For infusion therapy, the prior authorization must include all codes billed, including administration codes, or penalties will be applied to the claim.
Watch 66683
Get one email when a payer policy names 66683, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for 66683
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 66683 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.